Vaccitech plc is a fast-growing biotech company. At only six years old we already have a development portfolio of nine programmes, including a partnered product that is in commercial production and that has seen more than 3 billion doses administered worldwide and an IPO behind us. We are a publicly-listed clinical stage biopharmaceutical company that spun out of the University of Oxford’s Jenner Institute, one of the most prestigious vaccine research centres in the world. We discover and develop immunotherapeutic products and vaccines for the treatment and prevention of infectious diseases, cancer, and autoimmunity. Our achievements include co-inventing and jointly developing our COVID-19 vaccine candidate VTP-900, now Vaxzevria, which we assigned to Oxford University Innovation to facilitate the licensing of those rights to AstraZeneca. We run clinical studies to explore treatments for patients with HBV and HPV infections and are developing rapid and scalable manufacturing processes for our platforms.
In December 2021, Vaccitech acquired Avidea Technologies Inc. with exciting product candidates for oncology and autoimmunity based on the innovative SNAPvax platform, which has demonstrated unprecedented control over T cell induction. This enhances our U.S operational presence in Maryland, complements Vaccitech’s established capabilities and reinforces our position as a fast-growing global leader in immunotherapies and vaccines. Vaccitech's UK headquarters has recently moved to a state-of-the-art facility in the UK's leading science and innovation campus at Harwell. We conduct research globally and have ambitious plans in the UK and US, where we will continue to grow our teams over the coming months and years.
To support Vaccitech’s continued growth we are seeking a senior programme management leader to manage our team of Programme Managers in the US and UK, which currently has a headcount of four Programme Managers. We have a modest target of doubling team personnel over the next year. The Head of Programme Management will be responsible for driving this growth as well as giving strategic oversight for the direction of the team, the portfolio and accountability for the budget . Leading from the front, the Head of Programme Management will also take hands-on responsibility for managing at least one programme within the business.
Qualifications and experience required
- The successful candidate will possess a graduate degree in a life science discipline and have a minimum of 10 years of experience in programme and/or senior management in a small to mid-sized biotech.
- Early, through late phase clinical development experience in immunotherapeutics and vaccines will be a distinct advantage.
- PMP/PgMP or Axelos PRINCE2/MSP certification is also advantageous.
- You are a confident business leader who can effectively communicate, influence and command respect at all levels of the organization.
- You possess demonstrable leadership skills and experience.
What we can offer you
Vaccitech is a great place to work. We encourage an entirely flat structure with an open-door policy for the senior leadership team. Our employees agree the culture and working environment are one of the best things about our business.
This is a senior leadership role in a rapidly growing biotech that has the potential to fast-track the successful applicant’s career in an exciting area of research. As part of a small high growth business, you will get the opportunity to be involved in many different areas and our rapid growth trajectory means you will have the opportunity to grow with us.
We offer flexible forms of hybrid working, stock options to all employees, 25 days of annual holidays increasing with length of service, an AXA Healthcare plan, Life Insurance, and up to 5% pension contributions matched by the company.